https://novaprd-lb.newcastle.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:29893 Tue 25 Jul 2023 12:08:41 AEST ]]> Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:7448 Sat 24 Mar 2018 08:38:51 AEDT ]]> Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem) https://novaprd-lb.newcastle.edu.au/vital/access/manager/Repository/uon:16286 Sat 24 Mar 2018 07:59:27 AEDT ]]>